Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Real-World Safety and Efficacy of Teneligliptin in Japanese Patients With Type 2 Diabetes
jRCT1080222993Completed
- Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of teneligliptin in type 2 diabetes mellitus (T2DM), sponsored by Mitsubishi Tanabe Pharma Corporation. Primary endpoints: Long-term safety of teneligliptin in real-world use and Long-term effectiveness of teneligliptin. Started Oct 2015; status: completed.
02
Drugs
teneligliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT1080222993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080222993.